Invention Publication
- Patent Title: Reconstituted HDL Formulation
-
Application No.: US17902580Application Date: 2022-09-02
-
Publication No.: US20230142696A1Publication Date: 2023-05-11
- Inventor: Yvonne Vucica , Gary Lee Warren
- Applicant: CSL Limited
- Applicant Address: AU Parkville
- Assignee: CSL Limited
- Current Assignee: CSL Limited
- Current Assignee Address: AU Parkville
- Priority: WO 153903.3 2013.02.04 AU 13205684 2013.04.10
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K47/26 ; A61K47/10 ; A61K9/00 ; A61K9/19 ; C07K14/775 ; A61K47/24
Abstract:
The present invention relates to reconstituted high density lipoprotein (rHDL) formulations comprising an apolipoprotein, a lipid and a lyophilization stabilizer. Said formulations have reduced renal toxicity and good long-term stability, especially in lyophilized form.
Public/Granted literature
- US11957731B2 Reconstituted HDL formulation Public/Granted day:2024-04-16
Information query
IPC分类:
